121 related articles for article (PubMed ID: 3951166)
1. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
[TBL] [Abstract][Full Text] [Related]
2. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
[TBL] [Abstract][Full Text] [Related]
4. Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma.
Korenaga D; Saeki H; Mawatari K; Orita H; Maekawa S; Ikeda T; Sugimachi K
Arch Surg; 1997 Feb; 132(2):188-94. PubMed ID: 9041925
[TBL] [Abstract][Full Text] [Related]
5. Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease.
Staab HJ; Anderer FA
Cancer Detect Prev; 1983; 6(1-2):33-9. PubMed ID: 6883391
[TBL] [Abstract][Full Text] [Related]
6. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
7. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
Kjaer M; Fischerman K
Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
[TBL] [Abstract][Full Text] [Related]
10. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer.
Staab HJ; Anderer FA; Stumpf E; Hornung A; Fischer R; Kieninger G
Am J Surg; 1985 Feb; 149(2):198-204. PubMed ID: 3970315
[TBL] [Abstract][Full Text] [Related]
11. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.
Steele G; Ellenberg S; Ramming K; O'Connell M; Moertel C; Lessner H; Bruckner H; Horton J; Schein P; Zamcheck N; Novak J; Holyoke ED
Ann Surg; 1982 Aug; 196(2):162-9. PubMed ID: 7046656
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing growth rate of recurrent stomach cancers as determined by analysis of serum carcinoembryonic antigen.
Takahashi Y; Mai M; Kusama S
Cancer; 1995 Mar; 75(6 Suppl):1497-502. PubMed ID: 7889481
[TBL] [Abstract][Full Text] [Related]
13. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.
Kohler JP; Simonowitz D; Paloyan D
Am Surg; 1980 Aug; 46(8):449-52. PubMed ID: 7406353
[TBL] [Abstract][Full Text] [Related]
14. [Carcino-embryonic antigen as screening protein in the follow-up of patients with surgically-treated gastrointestinal cancer (author's transl)].
Möschl P; Staritz C; Keiler A; Kreuzer W; Fasching W
Wien Klin Wochenschr; 1980 Feb; 92(4):128-30. PubMed ID: 7395229
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer.
Wedell J; Meier zu Esssen P; Luu TH; Fiedler R; van Calker H; Koldowski P; Schlipköter HW
Dis Colon Rectum; 1981; 24(8):618-21. PubMed ID: 7318628
[TBL] [Abstract][Full Text] [Related]
17. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas.
Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y
Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
[No Abstract] [Full Text] [Related]
19. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
Quentmeier A; Schlag P; Herfarth C
Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
[TBL] [Abstract][Full Text] [Related]
20. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.
Sugarbaker PH; Zamcheck N; Moore FD
Cancer; 1976 Dec; 38(6):2310-5. PubMed ID: 1000469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
